-
The MIRD Perspective 1999
The Journal of Nuclear Medicine, 40:1 (January 1999)
Member Price: $30.00
NonMember Price: $42.00
Purchase Now
-
PET/CT Supplement to JNM January 2004
Member Price: $20.00
NonMember Price: $50.00
Purchase Now
-
Clinical Practice of Molecular Radiotherapy (Jan 2005)
The Journal of Nuclear Medicine, Supplement 46:1 (January 2005)
Editors: Steven M. Larson, MD, and Eric P. Krenning, MD, PhD
This collection of reviews on targeted radionuclide therapy provides a snapshot of the current status of modern clinical applications of therapeutic nuclear medicine.
Member Price: $34.00
NonMember Price: $54.00
Purchase Now
-
PET/CT in Cancer Patient Management
This peer-reviewed supplement to The Journal of Nuclear Medicine (48-1, Jan. 2007) will help physiciansincluding oncologists, internists, general practitioners, and radiologistsselect the imaging modality that best serves their patients. Articles focus on utilizing PET/CT technology in the diagnosis and care of cancer patients, including screening, detection, and management of cancer, particularly for thoracic, chest, abdominal, thyroid, head and neck cancers.
Member Price: $23.00
NonMember Price: $33.00
Purchase Now
-
Molecular Imaging of Cancer: From Molecules to Humans
The Journal of Nuclear Medicine, 49:2 (August 2006)
Guest Editor: Sanjiv S. Gambhir, MD, PhD
This supplement includes reviews of the major areas in which molecular imaging of cancer management was making progress in 2006. Although many other areas could also easily be a part of this supplement, the areas reviewed were chosen to familiarize the reader with the state of the art of the predominant strategies for using molecular imaging in the management of cancer. A multimodality perspective is used, in which both radionuclide-based methods with SPECT and PET and nonradionuclide-based methods including MRI, MR spectroscopy, optical imaging, and ultrasound imaging are discussed for each major area.
Member Price: $41.00
NonMember Price: $48.00
Purchase Now
-
Personalizing Cancer Therapy with FDG PET.. (May 2009)
Understand the clinical role of FDG PET in monitoring therapy responses in cancer patients.
Member Price: $29.00
NonMember Price: $39.00
Purchase Now
-
Multimodality Molecular Imaging of the Cardiovascular..05/10
Multimodality Molecular Imaging of the Cardiovascular System, a supplement to the top-rated Journal of Nuclear Medicine, presents the state of the art of cardiovascular molecular imaging and provides discussion of the opportunities and challenges in advancing cardiovascular molecular imaging to clinical practice.
Member Price: $29.00
NonMember Price: $39.00
Purchase Now
-
Issues and Controversies in Nuclear Medicine
The Journal of Nuclear Medicine, Supplement 52:2 (December 2011)
Editors: Johannes Czernin, MD; Wolfgang Weber, MD; Heinrich Schelbert, MD, PhD
This special issue of The Journal of Nuclear Medicine addresses the current state of and developments in radionuclide imaging as well as limitations, threats, and possible solutions.
Member Price: $29.00
NonMember Price: $39.00
Purchase Now
-
PET/MR Imaging: Potential Clinical and Research Applications
JNM Volume 55, Supplement 2 (June 2014)
Member Price: $21.00
NonMember Price: $29.00
Purchase Now
-
Clinical and Translational Theranostics
The Journal of Nuclear Medicine, Supplement 58:1 (June 2008)
Editors: Ken Herrmann, MD, MBA; Steven M. Larson, MD; and Wolfgang A. Weber, MD
The past year has seen unprecedented progress in the field of nuclear theranostics, particularly for treatment of neuroendocrine tumors and advanced prostate cancer. Against the backdrop of these recent successes, this publication of The Journal of Nuclear Medicine offers a detailed overview of targeted radionuclide therapy in thyroid cancer, neuroendocrine tumors, and prostate cancer and summarizes other applications of nuclear theranosticsas well as new developments on the horizon.
Member Price: $45.00
NonMember Price: $63.00
Purchase Now
